Nanobiotix S.A.
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-8.97-32.56-49.75-9.02
Price/Sales ratio
4.163.282.832.67
Earnings per Share (EPS)
$-0.66$-0.18$-0.12$-0.66

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-18.89-13.00-11.25-9.42-9.71-6.43-9.79-5.26-2.09-6.12-10.92-6.43
Price/Sales ratio
186.62832.51158.10978.362.50K4.81K6.58K24.74K25.018.09158.474.81K
Price/Book Value ratio
5.9514.1614.155.6120.39-171.564.679.23-4.41-131.894.19-171.56
Price/Cash Flow ratio
-21.08-13.14-13.47-11.72-11.17-7.95-11.95-8.28-3.21-19.49N/A-11.17
Price/Free Cash Flow ratio
-18.95-12.07-13.18-10.95-10.96-7.68-11.90-8.21-3.21-18.98N/A-10.96
Price/Earnings Growth ratio
7.17-0.20-0.58-1.92-7.28-0.110.232.42-0.090.17N/A-7.28
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
100%-35.42%71.99%-37.15%100%100%100%100%79.37%100%100%100%
Operating Profit Margin
-994.29%-6455.31%-1402.64%-10027.87%-25919.82%-68792.64%-72856%-525790%-977.84%-89.09%-1295.56%-25919.82%
Pretax Profit Margin
-979.56%-6403.13%-1398.50%-10375.61%-26159.48%-74870.58%-67228%-469989.99%-1194.15%-131.67%-1450.17%-26159.48%
Net Profit Margin
-987.75%-6403.13%-1404.30%-10375.62%-25772.41%-74875%-67246%-470039.99%-1194.36%-132.07%-1450.24%-25772.41%
Effective Tax Rate
-0.83%-0.22%-0.41%-0.00%1.47%-0.00%-0.02%-0.01%-0.01%-0.30%-0.00%-0.00%
Return on Assets
-25.79%-64.36%-71.96%-45.49%-64.71%-90.58%-25.08%-46.18%-95.43%-42.28%-10.11%-64.71%
Return On Equity
-31.52%-108.91%-125.76%-59.52%-209.89%2667.10%-47.71%-175.45%210.91%2152.92%-35.33%-209.89%
Return on Capital Employed
-29.48%-88.74%-98.63%-52.51%-86.90%-111.75%-31.67%-80.98%-213.90%-60.82%-14.15%-86.90%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/A6.57N/AN/AN/A2.52N/A
Quick Ratio
7.913.063.876.203.583.028.692.601.301.742.273.02
Cash ratio
7.452.392.555.043.122.446.252.271.091.502.272.44
Days of Sales Outstanding
0.61109.991.21244.8178.6659.0428.32K252.79K7.7136.02N/A59.04
Days of Inventory outstanding
N/A1.22K-4.20K-5.17KN/AN/AN/AN/A1.10KN/AN/AN/A
Operating Cycle
N/A1.33K-4.20K-4.92KN/AN/AN/AN/A1.11KN/AN/AN/A
Days of Payables Outstanding
N/A3.63K3.65K5.43KN/AN/AN/AN/A1.48KN/AN/AN/A
Cash Conversion Cycle
N/A-2.30K-7.86K-10.36KN/AN/AN/AN/A-369.50N/AN/AN/A
Debt Ratios
Debt Ratio
0.060.170.180.070.440.670.310.380.790.480.730.44
Debt Equity Ratio
0.070.290.320.101.44-19.960.601.47-1.76-24.662.791.44
Long-term Debt to Capitalization
0.060.180.200.070.581.050.350.542.591.04N/A1.05
Total Debt to Capitalization
0.070.220.240.090.591.050.370.592.311.04N/A1.05
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/A-109.54N/AN/AN/A7.69N/A
Cash Flow to Debt Ratio
-3.68-3.65-3.22-4.65-1.26-1.07-0.64-0.75-0.77-0.27N/A-1.26
Company Equity Multiplier
1.221.691.741.303.24-29.441.903.79-2.20-50.923.793.24
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-8.85-63.34-11.73-83.47-224.00-605.42-550.76-2.98K-7.76-0.41N/A-224.00
Free Cash Flow / Operating Cash Flow Ratio
1.111.081.021.061.011.031.001.001.001.02N/A1.03
Cash Flow Coverage Ratio
-3.68-3.65-3.22-4.65-1.26-1.07-0.64-0.75-0.77-0.27N/A-1.26
Short Term Coverage Ratio
-26.68-15.71-16.86-27.31-51.97-82.33-7.49-4.22-10.31-3.26N/A-51.97
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A